We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+7.78%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$964M
AUM Growth
-$12.5M
Cap. Flow
-$128M
Cap. Flow %
-13.3%
Top 10 Hldgs %
20.42%
Holding
244
New
38
Increased
54
Reduced
37
Closed
49

Top Buys

Rank Stock Value
1
FTAI icon
FTAI Aviation
FTAI
+$12.1M
2
EMBJ
Embraer S.A. ADS
EMBJ
+$11.5M
3
HALO icon
Halozyme
HALO
+$6.7M
4
SKYW icon
Skywest
SKYW
+$6.37M
5
RVMD icon
Revolution Medicines
RVMD
+$5.91M

Sector Composition

Rank Sector Weight
1 Technology 24.32%
2 Industrials 22.79%
3 Healthcare 13.53%
4 Financials 9.06%
5 Energy 7.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASND icon
101
Ascendis Pharma A/S
ASND
$16.8B
$3.17M 0.33%
23,216
+5,232
+29% +$712K
AAPL icon
102
Apple
AAPL
$4.57T
$3.14M 0.33%
14,916
+6,279
+73% +$1.17M
WT icon
103
WisdomTree
WT
$3.22B
$3.12M 0.32%
314,911
+2,931
+0.9% +$27.6K
BLBD icon
104
Blue Bird Corp
BLBD
$2.18B
$2.87M 0.3%
+53,208
New +$2.45M
SLN
105
Silence Therapeutics
SLN
$564M
$2.86M 0.3%
+150,480
New +$3.2M
INTU icon
106
Intuit
INTU
$89B
$2.67M 0.28%
4,063
-736
-15% -$457K
VRTX icon
107
Vertex Pharmaceuticals
VRTX
$126B
$2.64M 0.27%
5,636
+1,293
+30% +$561K
CORZ icon
108
Core Scientific
CORZ
$6.75B
$2.59M 0.27%
+278,407
New +$1.42M
C icon
109
Citigroup
C
$226B
$2.54M 0.26%
40,000
BRCC icon
110
BRC Inc
BRCC
$250M
$2.52M 0.26%
410,541
-142,870
-26% -$743K
IDYA icon
111
IDEAYA Biosciences
IDYA
$3.56B
$2.49M 0.26%
71,036
-84,784
-54% -$3.36M
SHOP icon
112
Shopify
SHOP
$195B
$2.42M 0.25%
36,711
CRNX icon
113
Crinetics Pharmaceuticals
CRNX
$8.92B
$2.37M 0.25%
+53,012
New +$2.45M
CFLT
114
DELISTED
Confluent
CFLT
$2.22M 0.23%
75,205
-82,189
-52% -$2.36M
LRCX icon
115
Lam Research
LRCX
$390B
$2.21M 0.23%
20,760
+520
+3% +$49.9K
KALV
116
DELISTED
KalVista Pharmaceuticals
KALV
$2.17M 0.23%
184,358
+1,714
+0.9% +$20K
VERA icon
117
Vera Therapeutics
VERA
$2.36B
$2.14M 0.22%
+59,129
New +$2.35M
DELL icon
118
Dell
DELL
$293B
$2.07M 0.21%
+14,990
New +$2.01M
S icon
119
SentinelOne
S
$7.34B
$2.05M 0.21%
97,606
-104,362
-52% -$2.14M
ARIS
120
DELISTED
Aris Water Solutions
ARIS
$1.7M 0.18%
+108,696
New +$1.63M
CW icon
121
Curtiss-Wright
CW
$25.5B
$1.67M 0.17%
6,171
+1,333
+28% +$356K
VRT icon
122
Vertiv
VRT
$105B
$1.67M 0.17%
19,309
-7,604
-28% -$692K
BHVN icon
123
Biohaven
BHVN
$2.21B
$1.6M 0.17%
45,966
-136,697
-75% -$5.4M
DKNG icon
124
DraftKings
DKNG
$11.9B
$1.55M 0.16%
40,647
+6,987
+21% +$290K
PANW icon
125
Palo Alto Networks
PANW
$297B
$1.43M 0.15%
8,440
-8,416
-50% -$1.26M

Similar funds

Nicholas Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Nicholas Investment Partners held 244 positions worth $964M, down 1.3% from $976M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Nicholas Investment Partners withdrew a net $128M in Q2 2024, closing 49 positions and reducing 37 holdings. Its most notable exit was Celsius Holdings, an estimated $10.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Nicholas Investment Partners opened a new position in FTAI Aviation worth $15.7M.

  • Nicholas Investment Partners's largest Q2 2024 buy was FTAI Aviation: 152,258 shares worth $15.7M.
  • Nicholas Investment Partners added most to Embraer S.A. ADS in Q2 2024, an estimated $11.5M increase.
  • Nicholas Investment Partners's biggest Q2 2024 reduction was Super Micro Computer, cutting an estimated $8.1M.
  • Nicholas Investment Partners fully exited Celsius Holdings in Q2 2024, selling an estimated $10.5M.
  • Nicholas Investment Partners's ten largest holdings make up 20% of its $964M portfolio in Q2 2024.
  • Nicholas Investment Partners opened 38 new positions and closed 49 in Q2 2024.
  • Nicholas Investment Partners's portfolio value fell 1.3% quarter-over-quarter to $964M.

Based on Nicholas Investment Partners's 13F filing for Q2 2024, filed 8 Aug 2024.